AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Fineo, A Scalise, G
Citation: A. Giacometti et al., Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture, J ANTIMICRO, 47(1), 2001, pp. 97-99
Effect of mono-dose intraperitoneal cecropins in experimental septic shock
Authors: Giacometti, A Cirioni, O Ghiselli, R Viticchi, C Mocchegiani, F Riva, A Saba, V Scalise, G
Citation: A. Giacometti et al., Effect of mono-dose intraperitoneal cecropins in experimental septic shock, CRIT CARE M, 29(9), 2001, pp. 1666-1669
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron
Authors: Ghiselli, R Giacometti, A Goffi, L Cirioni, O Mocchegiani, F Orlando, F Paggi, AM Petrelli, E Scalise, G Saba, V
Citation: R. Ghiselli et al., Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron, J SURG RES, 99(2), 2001, pp. 316-320
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia
Authors: Ghiselli, R Giacometti, A Cirioni, O Orlando, F Mocchegiani, F Pacci, AM Scalise, G Saba, V
Citation: R. Ghiselli et al., Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia, J SURG RES, 100(2), 2001, pp. 183-188
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection
Authors: Ghiselli, R Giacometti, A Goffi, L Cirioni, O Boccoli, G Mocchegiani, F Riva, A Scalise, G Saba, V
Citation: R. Ghiselli et al., Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection, EUR J VAS E, 20(6), 2000, pp. 508-511
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics
Authors: Giacometti, A Cirioni, O Barchiesi, F Scalise, G
Citation: A. Giacometti et al., In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics, DIAG MICR I, 38(2), 2000, pp. 115-118
Environmental and serological evidence for the presence of toxocariasis inthe urban area of Ancona, Italy
Authors: Giacometti, A Cirioni, O Fortuna, M Osimani, P Antonicelli, L Del Prete, MS Riva, A D'Errico, MM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Environmental and serological evidence for the presence of toxocariasis inthe urban area of Ancona, Italy, EUR J EPID, 16(11), 2000, pp. 1023-1026
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis
Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Mocchegiani, F Riva, A Scalise, G Saba, V
Citation: A. Giacometti et al., Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis, J ANTIMICRO, 46(5), 2000, pp. 751-756
Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Paggi, AM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii, J ANTIMICRO, 46(5), 2000, pp. 807-810
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline
Authors: Cirioni, O Giacometti, A Barchiesi, F Scalise, G
Citation: O. Cirioni et al., Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline, J ANTIMICRO, 46(4), 2000, pp. 577-582
In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems
Authors: Giacometti, A Cirioni, O Barchiesi, F Ancarani, F Scalise, G
Citation: A. Giacometti et al., In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems, J ANTIMICRO, 45(5), 2000, pp. 651-654
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture
Authors: Giacometti, A Cirioni, O Barchiesi, F Ancarani, F Scalise, G
Citation: A. Giacometti et al., Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture, J ANTIMICRO, 45(4), 2000, pp. 453-456
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines
Authors: Giacometti, A Cirioni, O Barchiesi, F Scalise, G
Citation: A. Giacometti et al., Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines, J ANTIMICRO, 45(3), 2000, pp. 375-377
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria
Authors: Giacometti, A Cirioni, O Del Prete, MS Paggi, AM D'Errico, MM Scalise, G
Citation: A. Giacometti et al., Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria, PEPTIDES, 21(8), 2000, pp. 1155-1160
Epidemiology and microbiology of surgical wound infections
Authors: Giacometti, A Cirioni, O Schimizzi, AM del Prete, MS Barchiesi, F D'Errico, MM Petrelli, E Scalise, G
Citation: A. Giacometti et al., Epidemiology and microbiology of surgical wound infections, J CLIN MICR, 38(2), 2000, pp. 918-922
In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically
Authors: Giacometti, A Cirioni, O Barchiesi, F Del Prete, MS Fortuna, M Caselli, F Scalise, G
Citation: A. Giacometti et al., In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically, ANTIM AG CH, 44(6), 2000, pp. 1694-1696
In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Fortuna, M Drenaggi, D Scalise, G
Citation: A. Giacometti et al., In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia, ANTIM AG CH, 44(6), 2000, pp. 1716-1719
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection
Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Mocchegiani, F Riva, A Scalise, G Saba, V
Citation: A. Giacometti et al., Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection, ANTIM AG CH, 44(12), 2000, pp. 3306-3309
Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture
Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Scalise, G
Citation: A. Giacometti et al., Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture, ANTIM AG CH, 44(12), 2000, pp. 3473-3475
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection
Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Viticchi, C Mocchegiani, F Riva, A Orlando, F Saba, V Scalise, G
Citation: A. Giacometti et al., Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection, ANTIM AG CH, 44(10), 2000, pp. 2842-2844
Irritable bowel syndrome in patients with Blastocystis hominis infection
Authors: Giacometti, A Cirioni, O Fiorentini, A Fortuna, M Scalise, G
Citation: A. Giacometti et al., Irritable bowel syndrome in patients with Blastocystis hominis infection, EUR J CL M, 18(6), 1999, pp. 436-439
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis
Authors: Giacometti, A Burzacchini, F Cirioni, O Barchiesi, F Dini, M Scalise, G
Citation: A. Giacometti et al., Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis, EUR J CL M, 18(12), 1999, pp. 885-889
In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics
Authors: Giacometti, A Cirioni, O Barchiesi, F Fortuna, M Scalise, G
Citation: A. Giacometti et al., In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics, EUR J CL M, 18(11), 1999, pp. 827-829
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts
Authors: Cirioni, O Giacometti, A Drenaggi, D Ancarani, F Scalise, G
Citation: O. Cirioni et al., Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts, EUR J EPID, 15(4), 1999, pp. 389-393
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa
Authors: Giacometti, A Cirioni, O Barchiesi, F Fortuna, M Scalise, G
Citation: A. Giacometti et al., In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa, J ANTIMICRO, 44(5), 1999, pp. 641-645
Risultati: 1-25 | 26-32